Search results: Sage Journals

Open accessResearch articleFirst published July, 2026

Efficacy evaluation of novel targeted drugs in patients with human epidermal growth factor receptor 2-positive breast cancer: A meta-analysis based on multiple sets of clinical data

Yingmei Lan, Rongzhong Wang, Sijia Liu

Journal of International Medical Research

Open accessReview articleFirst published April, 2022

Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Jindong Xie, Yutian Zou, Ting Gao [...]

Cancer Control

Open accessBook reviewFirst published May, 2022

Systemic Treatments for Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Old Certainties and New Frontiers

Alessandro Rizzo, Antonio Cusmai, Raffaella Massafra [...]

Cancer Control

Open accessReview articleFirst published 2021

Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer

Huimin Lv, Min Yan, Zefei Jiang

Therapeutic Advances in Medical Oncology

Available accessReview articleFirst published August, 2021

Treatment outcomes among human epidermal growth factor receptor 2 positive breast cancer patients: A systematic review

Amsalu Degu, Asha Yussuf

Journal of Oncology Pharmacy Practice

Open accessReview articleFirst published 2015

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive,Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Adam M. Brufsky

Clinical Medicine Insights: Oncology

Free accessReview articleFirst published November, 2015

Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options

Hanfang Jiang, Hope S. Rugo

Therapeutic Advances in Medical Oncology

Free accessResearch articleFirst published August, 2019

Intratumoral Estrogen Receptor Heterogeneity of Expression in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer as Evaluated by a Brightfield Multiplex Assay

Shinobu Masuda, Hiroaki Nitta, Brian D. Kelly [...]

Journal of Histochemistry & Cytochemistry

Open accessResearch articleFirst published 2024

Combination of Palbociclib and Endocrine Therapy in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With or Without Brain Metastases

Qiuyi Zhang, Xiaofeng Lan, Jiayi Huang [...]

Technology in Cancer Research & Treatment

Free accessReview articleFirst published September, 2012

The potential for trastuzumab emtansine in human epidermal growth factor receptor 2 positive metastatic breast cancer: latest evidence and ongoing studies

Sara A. Hurvitz, Reva Kakkar

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published July, 2026

Efficacy evaluation of novel targeted drugs in patients with human epidermal growth factor receptor 2-positive breast cancer: A meta-analysis based on multiple sets of clinical data

Yingmei Lan, Rongzhong Wang, Sijia Liu

Journal of International Medical Research

Open accessReview articleFirst published April, 2022

Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Jindong Xie, Yutian Zou, Ting Gao [...]

Cancer Control

Open accessBook reviewFirst published May, 2022

Systemic Treatments for Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Old Certainties and New Frontiers

Alessandro Rizzo, Antonio Cusmai, Raffaella Massafra [...]

Cancer Control

Open accessReview articleFirst published 2021

Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer

Huimin Lv, Min Yan, Zefei Jiang

Therapeutic Advances in Medical Oncology

Available accessReview articleFirst published August, 2021

Treatment outcomes among human epidermal growth factor receptor 2 positive breast cancer patients: A systematic review

Amsalu Degu, Asha Yussuf

Journal of Oncology Pharmacy Practice

Open accessReview articleFirst published 2015

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive,Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Adam M. Brufsky

Clinical Medicine Insights: Oncology

Free accessReview articleFirst published November, 2015

Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options

Hanfang Jiang, Hope S. Rugo

Therapeutic Advances in Medical Oncology

Free accessResearch articleFirst published August, 2019

Intratumoral Estrogen Receptor Heterogeneity of Expression in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer as Evaluated by a Brightfield Multiplex Assay

Shinobu Masuda, Hiroaki Nitta, Brian D. Kelly [...]

Journal of Histochemistry & Cytochemistry

Open accessResearch articleFirst published 2024

Combination of Palbociclib and Endocrine Therapy in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With or Without Brain Metastases

Qiuyi Zhang, Xiaofeng Lan, Jiayi Huang [...]

Technology in Cancer Research & Treatment

Free accessReview articleFirst published September, 2012

The potential for trastuzumab emtansine in human epidermal growth factor receptor 2 positive metastatic breast cancer: latest evidence and ongoing studies

Sara A. Hurvitz, Reva Kakkar

Therapeutic Advances in Medical Oncology